Navigation Links
Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
Date:5/21/2012

g the pathologies of some central nervous system conditions.  The company has received approval from the FDA to conduct a Phase Ib safety trial evaluating NSI-189, its first neurogenic small molecule compound, for the treatment of major depressive disorder (MDD).  Additional indications could include CTE (chronic traumatic encephalopathy), Alzheimer's disease, anxiety, and memory disorders.

For more information, please visit www.neuralstem.com or connect with us on Twitter and Facebook.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem's periodic reports, including the annual report on Form 10-K for the year ended December 31, 2011 and the Form 10-Q for the period ended March 30, 2012.


'/>"/>
SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
2. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering
3. Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012
4. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
5. Neuralstem ALS Stem Cell Trial Featured on Fox Atlanta
6. Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
7. Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference
8. Neuralstem Awarded Department of Defense Contract for Brain Cancer Research
9. Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update
10. Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstems Board
11. Neuralstem, Inc. Settles Litigation Against ReNeuron, Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 TransVac Solutions, the trusted leader ... transport solutions for hospitals, will be exhibiting at booth ... Annual Conference & Technical Exhibition Aug. 3-6 in Chicago, ... for making hospitals cleaner, reducing infection risk and saving ... life cycle. Staff will be available at booth ...
(Date:7/29/2014)... Carolina (PRWEB) July 29, 2014 DisasterTalk is ... of people where cell phone masts or other transmitters are ... to 100 feet away without the need for any Wi-Fi, ... longer ranges. , The new app has launched as a ... homes are at very high risk of being affected by ...
(Date:7/29/2014)... Eppendorf Centrifuge 5427 R ... 5427 R is geared towards high-end applications like genomic, ... targeted towards work requiring high sample throughput. Pipette.com is ... compliments their extensive 16, 48, and 64 multichannel pipettes ... PCR tubes, PCR strip tubes, and more. , ...
(Date:7/29/2014)... , July 29, 2014 ... System (LBS) zur Erfassung biologischer Daten in ... entwickelt und patentiert. Das LBS nimmt gleichzeitig ... Koronararterie des Patienten und sucht erhöhte biologische ... das Potenzial, die Entdeckung und Entwicklung neuer ...
Breaking Biology Technology:TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2DisasterTalk App Could Save Lives as Report Reveals 8% of US Homes at Very High Risk of Natural Disaster 2International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio 2PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 2PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 4
... Texas, May 31, 2011 Lexicon Pharmaceuticals, Inc. ... focused on discovering breakthrough treatments for human disease, announced ... Lexicon,s president and chief executive officer, will present at ... 8, 2011 at 10:30 a.m. Eastern Time in New ...
... 31, 2011 DIME announces ... browser that is designed to deliver targeted, relevant content ... steadily on the rise among physicians. Currently over 86 ... drug information online, according to a recent study.  DIME,s ...
... Reportlinker.com announces that a new market ... Global Cell/Tissue Culture Supplies ... This report analyzes the ... US$ Million by the following Product Segments: ...
Cached Biology Technology:Lexicon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference 2Physicians' Growing Demand for Point-of-Care Resources Spawns iPointOfCare From Top Continuing Medical Education Provider; DIME 2Global Cell/Tissue Culture Supplies Industry 2Global Cell/Tissue Culture Supplies Industry 3Global Cell/Tissue Culture Supplies Industry 4Global Cell/Tissue Culture Supplies Industry 5Global Cell/Tissue Culture Supplies Industry 6Global Cell/Tissue Culture Supplies Industry 7Global Cell/Tissue Culture Supplies Industry 8Global Cell/Tissue Culture Supplies Industry 9Global Cell/Tissue Culture Supplies Industry 10Global Cell/Tissue Culture Supplies Industry 11Global Cell/Tissue Culture Supplies Industry 12Global Cell/Tissue Culture Supplies Industry 13Global Cell/Tissue Culture Supplies Industry 14Global Cell/Tissue Culture Supplies Industry 15Global Cell/Tissue Culture Supplies Industry 16Global Cell/Tissue Culture Supplies Industry 17Global Cell/Tissue Culture Supplies Industry 18Global Cell/Tissue Culture Supplies Industry 19
(Date:7/28/2014)... professor John Essigmann and colleagues from the University of Washington ... if they could induce the virus to mutate uncontrollably, they ... a strategy that our immune system uses against many viruses. ... HIV to mutate at an enhanced rate, as expected. But ... small clinical trial reported in 2011. In a new study, ...
(Date:7/28/2014)... other forms of dementia, but the research community is ... Washington bioengineers have a designed a peptide structure that ... proteins into a state that,s linked to widespread diseases ... and Lou Gehrig,s disease. The synthetic molecule blocks these ... an abnormally folded form by targeting a toxic intermediate ...
(Date:7/28/2014)... 28, 2014) Rice University researchers are using magnetic ... flexibility that can be used as microscale models for ... "bead-spring" polymers, introduced as theory in the 1950s, can ... and should be of interest to materials scientists who ... led by Rice chemical and biomolecular engineer Sibani Lisa ...
Breaking Biology News(10 mins):Forced mutations doom HIV 2Forced mutations doom HIV 3Forced mutations doom HIV 4New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Seeing is bead-lieving 2
... LA A team of researchers led by Charles ... Health Sciences Center New Orleans, has successfully translated a ... to fruit flies. This powerful genetic tool ... scientists to selectively, rapidly, reversibly, and dose-dependently remotely control ...
... -- A study published in the September 2013 issue ... Child and Adolescent Psychiatry found that young adults ... transitioning into employment than their peers with different disabilities. ... 2 (NLTS2; a longitudinal nationally-representative survey of youth ages ...
... seven technical reports that together form the most ... natural gas and oil extraction process commonly known ... pages, examine seven critical topics related to the ... emphasis on high-volume methods: technology, geology and hydrogeology, ...
Cached Biology News:LSUHSC researchers develop new system to better study behavior, cell function 2Young adults with autism found to have difficulty transitioning into employment 2U-M technical reports examine hydraulic fracturing in Michigan 2U-M technical reports examine hydraulic fracturing in Michigan 3U-M technical reports examine hydraulic fracturing in Michigan 4U-M technical reports examine hydraulic fracturing in Michigan 5U-M technical reports examine hydraulic fracturing in Michigan 6U-M technical reports examine hydraulic fracturing in Michigan 7
Request Info...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
... I from E. coli is ... enzyme also contains both 5'--3'and ... exonuclease activity enables the enzyme ... in the DNA as starting ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
Biology Products: